Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 Technology today reported preliminary revenues of $2.2 million for its fiscal year ended July 31, compared to revenues of $1.3 million for FY 2009.

The Denver-based firm also reported net income of $650,447 for the year, compared to a net loss of $714,197 for the previous year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.